Matthay Zachary A, Pace William A, Smith Eric J, Gutierrez Richard D, Gasper Warren J, Hiramoto Jade S, Reilly Linda M, Conte Michael S, Iannuzzi James C
Department of Surgery, University of California, San Francisco, San Francisco, CA.
Department of Surgery, University of California, San Francisco, San Francisco, CA.
J Vasc Surg. 2024 Jun;79(6):1447-1456.e2. doi: 10.1016/j.jvs.2024.01.209. Epub 2024 Feb 2.
Inadequate vein quality or prior harvest precludes use of autologous single segment greater saphenous vein (ssGSV) in many patients with chronic limb-threatening ischemia (CLTI). Predictors of patient outcome after infrainguinal bypass with alternative (non-ssGSV) conduits are not well-understood. We explored whether limb presentation, bypass target, and conduit type were associated with amputation-free survival (AFS) after infrainguinal bypass using alternative conduits.
A single-center retrospective study (2013-2020) was conducted of 139 infrainguinal bypasses performed for CLTI with cryopreserved ssGSV (cryovein) (n = 71), polytetrafluoroethylene (PTFE) (n = 23), or arm/spliced vein grafts (n = 45). Characteristics, Wound, Ischemia, and foot Infection (WIfI) stage, and outcomes were recorded. Multivariable Cox proportional hazards and classification and regression tree analysis modeled predictors of AFS.
Within 139 cases, the mean age was 71 years, 59% of patients were male, and 51% of cases were nonelective. More patients undergoing bypass with cryovein were WIfI stage 4 (41%) compared with PTFE (13%) or arm/spliced vein (27%) (P = .04). Across groups, AFS at 2 years was 78% for spliced/arm, 79% for PTFE, and 53% for cryovein (adjusted hazard ratio for cryovein, 2.5; P = .02). Among cases using cryovein, classification and regression tree analysis showed that WIfI stage 3 or 4, age >70 years, and prior failed bypass were predictive of the lowest AFS at 2 years of 36% vs AFS of 58% to 76% among subgroups with less than two of these factors. Although secondary patency at 2 years was worse in the cryovein group (26% vs 68% and 89% in arm/spliced and PTFE groups; P < .01), in patients with tissue loss there was no statistically significant difference in wound healing in the cryovein group (72%) compared with other bypass types (72% vs 87%, respectively; P = .12).
In patients with CLTI lacking suitable ssGSV, bypass with autogenous arm/spliced vein or PTFE has superior AFS compared with cryovein, although data were limited for PTFE conduits for distal targets. Despite poor patency with cryovein, wound healing is achieved in a majority of cases, although it should be used with caution in older patients with high WIfI stage and prior failed bypass, given the low rates of AFS.
在许多患有慢性肢体威胁性缺血(CLTI)的患者中,静脉质量不佳或先前已进行过静脉采集,使得无法使用自体单段大隐静脉(ssGSV)。对于采用替代(非ssGSV)导管进行股下旁路移植术后患者预后的预测因素,目前尚不清楚。我们探讨了肢体表现、旁路移植目标以及导管类型与采用替代导管进行股下旁路移植术后无截肢生存期(AFS)之间是否存在关联。
对2013年至2020年在单中心进行的139例针对CLTI的股下旁路移植术进行回顾性研究,这些手术使用了冷冻保存的ssGSV(冷冻静脉)(n = 71)、聚四氟乙烯(PTFE)(n = 23)或手臂/拼接静脉移植物(n = 45)。记录患者的特征、伤口、缺血和足部感染(WIfI)分期以及预后情况。采用多变量Cox比例风险模型和分类与回归树分析对AFS的预测因素进行建模。
在139例病例中,平均年龄为71岁,59%的患者为男性,51%的病例为非择期手术。与PTFE组(13%)或手臂/拼接静脉组(27%)相比,更多接受冷冻静脉旁路移植术的患者处于WIfI 4期(41%)(P = 0.04)。在所有组中,拼接/手臂静脉组2年时的AFS为78%,PTFE组为79%,冷冻静脉组为53%(冷冻静脉的调整风险比为2.5;P = 0.02)。在使用冷冻静脉的病例中进行分类与回归树分析显示,WIfI 3期或4期、年龄>70岁以及先前旁路移植失败可预测2年时最低的AFS为36%,而在这些因素少于两项的亚组中AFS为58%至76%。尽管冷冻静脉组2年时的二次通畅率较差(26%,而手臂/拼接静脉组和PTFE组分别为68%和89%;P < 0.01),但在有组织缺损的患者中,冷冻静脉组的伤口愈合情况与其他旁路移植类型相比无统计学显著差异(分别为72%、72%和87%;P = 0.12)。
在缺乏合适ssGSV的CLTI患者中,与冷冻静脉相比,采用自体手臂/拼接静脉或PTFE进行旁路移植术具有更好的AFS,尽管针对远端目标的PTFE导管数据有限。尽管冷冻静脉的通畅性较差,但大多数病例仍可实现伤口愈合,不过鉴于AFS较低,对于WIfI分期高且先前旁路移植失败的老年患者应谨慎使用。